BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1608 related articles for article (PubMed ID: 25760630)

  • 1. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
    Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinin B1 receptor regulates muscle-specific E3 ligases expression and is involved in skeletal muscle mass control.
    Parreiras-E-Silva LT; Reis RI; Santos GA; Pires-Oliveira M; Pesquero JB; Gomes MD; Godinho RO; Costa-Neto CM
    Clin Sci (Lond); 2014 Aug; 127(3):185-94. PubMed ID: 24498923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
    Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
    PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo.
    Pires-Oliveira M; Maragno AL; Parreiras-e-Silva LT; Chiavegatti T; Gomes MD; Godinho RO
    J Appl Physiol (1985); 2010 Feb; 108(2):266-73. PubMed ID: 19926828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.
    Kimura N; Kumamoto T; Oniki T; Nomura M; Nakamura K; Abe Y; Hazama Y; Ueyama H
    Muscle Nerve; 2009 Apr; 39(4):521-8. PubMed ID: 19296457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I.
    Lang CH; Huber D; Frost RA
    Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R328-36. PubMed ID: 16946078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
    Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
    Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
    Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
    Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.
    Granado M; Martín AI; Priego T; López-Calderón A; Villanúa MA
    J Endocrinol; 2006 Oct; 191(1):319-26. PubMed ID: 17065414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation.
    Hirasaka K; Maeda T; Ikeda C; Haruna M; Kohno S; Abe T; Ochi A; Mukai R; Oarada M; Eshima-Kondo S; Ohno A; Okumura Y; Terao J; Nikawa T
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):317-24. PubMed ID: 24064732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor inoculation site affects the development of cancer cachexia and muscle wasting.
    Matsuyama T; Ishikawa T; Okayama T; Oka K; Adachi S; Mizushima K; Kimura R; Okajima M; Sakai H; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Kokura S; Naito Y; Itoh Y
    Int J Cancer; 2015 Dec; 137(11):2558-65. PubMed ID: 26016447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse.
    Caron AZ; Drouin G; Desrosiers J; Trensz F; Grenier G
    J Appl Physiol (1985); 2009 Jun; 106(6):2049-59. PubMed ID: 19342435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.